Device Trial Radar · NCT00604552
AneuRx Post Market Study in the Treatment of AAA
Last checked: Nov 20, 2026Latest source record: Oct 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
349
Actual
Start
Jul 2003
Primary completion
Feb 2008
Study completion Feb 2009
Sponsor
- Lead sponsor
- Medtronic CardiovascularPublic (MDT)
- Sponsor type
- Industry
- Collaborators
- Medtronic
- First posted
- Jan 30, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal consequences. Abdominal aortic aneurysm (AAA) is a life-threatening lesion that has been treated in recent year via endovascular repair. The purpose of this study is to monitor the long term performance of the AneuRx Stent Graft Systems.
Conditions
- Abdominal Aneurysm
Interventions
AneuRx Stent GraftDevice
Abdominal Aortic Aneurysm Repair
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the Occurrence of Death, Aneurysm Rupture, and Surgical ConversionTime frame: 5 year
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Tucson, Arizona
Site not named
Royal Oak, Michigan
Site not named
Morristown, New Jersey
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.